Protalix BioTherapeutics, Inc.
PLX
$1.98
$0.021.02%
AMEX
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 51.08M | 30.27M | 29.37M | 33.40M | 34.74M |
| Total Receivables | 2.94M | 9.47M | 14.43M | 9.44M | 4.68M |
| Inventory | 30.47M | 25.73M | 21.26M | 21.13M | 19.51M |
| Prepaid Expenses | -- | 394.00K | -- | -- | -- |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 1.86M | 803.00K | 1.45M | 1.51M | 1.59M |
| Total Current Assets | 86.36M | 66.67M | 66.50M | 65.49M | 60.51M |
|
|
|||||
| Total Current Assets | 86.36M | 66.67M | 66.50M | 65.49M | 60.51M |
| Net Property, Plant & Equipment | 12.95M | 12.58M | 12.53M | 9.74M | 9.95M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 3.03M | 3.09M | 3.23M | 3.26M | 3.43M |
| Total Assets | 102.34M | 82.35M | 82.26M | 78.49M | 73.89M |
|
|
|||||
| Total Accounts Payable | 4.29M | 5.26M | 5.38M | 6.69M | 4.12M |
| Total Accrued Expenses | 16.81M | 14.53M | 11.64M | 11.81M | 14.87M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 1.43M | 1.38M | 1.40M | 1.47M | 1.43M |
| Total Finance Division Other Current Liabilities | 4.86M | 5.35M | 3.54M | 4.12M | 3.90M |
| Total Other Current Liabilities | 4.86M | 5.35M | 3.54M | 4.12M | 3.90M |
| Total Current Liabilities | 27.39M | 26.52M | 21.95M | 24.09M | 24.32M |
|
|
|||||
| Total Current Liabilities | 27.39M | 26.52M | 21.95M | 24.09M | 24.32M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 7.05M | 6.94M | 6.78M | 3.88M | 3.81M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 671.00K | 661.00K | 631.00K | 615.00K | 551.00K |
| Total Liabilities | 35.11M | 34.12M | 29.36M | 28.58M | 28.68M |
|
|
|||||
| Common Stock & APIC | 433.91M | 433.23M | 432.40M | 431.75M | 427.22M |
| Retained Earnings | -366.68M | -385.00M | -379.49M | -381.85M | -382.01M |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | 67.23M | 48.23M | 52.91M | 49.90M | 45.21M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 67.23M | 48.23M | 52.91M | 49.90M | 45.21M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 67.23M | 48.23M | 52.91M | 49.90M | 45.21M |
|
|
|||||